Necl-5/Poliovirus Receptor Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis

被引:43
作者
Kinugasa, Mitsuo [1 ]
Amano, Hisayuki [4 ]
Satomi-Kobayashi, Seimi [1 ]
Nakayama, Kazuhiko [1 ]
Miyata, Muneaki
Kubo, Yoshiki [1 ]
Nagamatsu, Yuichi [4 ]
Kurogane, Yusuke
Kureha, Fumie [1 ]
Yamana, Shota [1 ]
Hirata, Ken-ichi [1 ]
Miyoshi, Jun [3 ]
Takai, Yoshimi [4 ]
Rikitake, Yoshiyuki [1 ,2 ,4 ]
机构
[1] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 6500017, Japan
[2] Kobe Univ, Grad Sch Med, Div Signal Transduct, Dept Biochem & Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan
[3] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Mol Biol, Osaka, Japan
[4] Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Kobe, Hyogo 6500017, Japan
基金
日本学术振兴会;
关键词
cell adhesion molecules; angiogenesis; peripheral vascular disease; ENDOTHELIAL GROWTH-FACTOR; CELL-MOVEMENT; IMMUNOGLOBULIN SUPERFAMILY; ACTIVATION; INTEGRIN; PROLIFERATION; MEMBER; GENE; ALPHA(V)BETA(3); EXPRESSION;
D O I
10.1161/CIRCRESAHA.111.256834
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Vascular endothelial growth factor (VEGF), a major proangiogenic agent, exerts its proangiogenic action by binding to VEGF receptor 2 (VEGFR2), the activity of which is regulated by direct interactions with other cell surface proteins, including integrin alpha(v)beta(3). However, how the interaction between VEGFR2 and integrin alpha(v)beta(3) is regulated is not clear. Objective: To investigate whether Necl-5/poliovirus receptor, an immunoglobulin-like molecule that is known to bind integrin alpha(v)beta(3), regulates the interaction between VEGFR2 and integrin alpha(v)beta(3), and to clarify the role of Necl-5 in the VEGF-induced angiogenesis. Methods and Results: Necl-5-knockout mice displayed no obvious defect in vascular development; however, recovery of blood flow after hindlimb ischemia and the VEGF-induced neovascularization in implanted Matrigel plugs were impaired in Necl-5-knockout mice. To clarify the mechanism of the regulation of angiogenesis by Necl-5, we investigated the roles of Necl-5 in the VEGF-induced angiogenic responses in vitro. Knockdown of Necl-5 by siRNAs in human umbilical vein endothelial cells (HUVECs) inhibited the VEGF-induced capillary-like network formation on Matrigel, migration, and proliferation, and conversely, enhanced apoptosis. Coimmunoprecipitation assays showed the interaction of Necl-5 with VEGFR2, and knockdown of Necl-5 prevented the VEGF-induced interaction of integrin alpha(v)beta(3) with VEGFR2. Knockdown of Necl-5 suppressed the VEGFR2-mediated activation of downstream proangiogenic and survival signals, including Rap1, Akt, and endothelial nitric oxide synthase. Conclusions: These results demonstrate the critical role of Necl-5 in angiogenesis and suggest that Necl-5 may regulate the VEGF-induced angiogenesis by controlling the interaction of VEGFR2 with integrin alpha(v)beta(3), and the VEGFR2-mediated Rap1-Akt signaling pathway. (Circ Res. 2012;110:716-726.)
引用
收藏
页码:716 / U197
页数:25
相关论文
共 46 条
  • [1] Role of Necl-5 in the pathophysiology of colorectal lesions induced by dimethylhydrazine and/or dextran sodium sulphate
    Abe, A.
    Fukui, H.
    Fujii, S.
    Kono, T.
    Mukawa, K.
    Yoshitake, N.
    Sekikawa, A.
    Ichikawa, K.
    Tomita, S.
    Yamagish, H.
    Imai, Y.
    Shinoda, M.
    Ishizaki, H.
    Tanaka-Okamoto, M.
    Kubota, K.
    Miyoshi, J.
    Takai, Y.
    Fujimori, T.
    [J]. JOURNAL OF PATHOLOGY, 2009, 217 (01) : 42 - 53
  • [2] Akt1/protein kinase Bα is critical for ischemic and VEGF-mediated angiogenesis
    Ackah, E
    Yu, J
    Zoellner, S
    Iwakiri, Y
    Skurk, C
    Shibata, R
    Ouchi, N
    Easton, RM
    Galasso, G
    Birnbaum, MJ
    Walsh, K
    Sessa, WC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (08) : 2119 - 2127
  • [3] Interaction and localization of Necl-5 and PDGF receptor β at the leading edges of moving NIH3T3 cells:: Implications for directional cell movement
    Amano, Hisayuki
    Ikeda, Wataru
    Kawano, Satoshi
    Kajita, Mihoko
    Tamaru, Yoshiyuki
    Inoue, Naoya
    Minami, Yukiko
    Yamada, Akio
    Takai, Yoshimi
    [J]. GENES TO CELLS, 2008, 13 (03) : 269 - 284
  • [4] Marching at the front and dragging behind:: differential α-Vβ3-integrin turnover regulates focal adhesion behavior
    Ballestrem, C
    Hinz, B
    Imhof, BA
    Wehrle-Haller, B
    [J]. JOURNAL OF CELL BIOLOGY, 2001, 155 (07) : 1319 - 1332
  • [5] BATTEGAY EJ, 1995, J MOL MED, V73, P333
  • [6] Platelet-derived growth factor receptor β and vascular endothelial growth factor receptor 2 bind to the β3 integrin through its extracellular domain
    Borges, E
    Jan, YW
    Ruoslahti, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (51) : 39867 - 39873
  • [7] A mechanism for modulation of cellular responses to VEGF: Activation of the integrins
    Byzova, TV
    Goldman, CK
    Pampori, N
    Thomas, KA
    Bett, A
    Shattil, SJ
    Plow, EF
    [J]. MOLECULAR CELL, 2000, 6 (04) : 851 - 860
  • [8] Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis
    Carmeliet, P
    Lampugnani, MG
    Moons, L
    Breviario, F
    Compernolle, V
    Bono, F
    Balconi, G
    Spagnuolo, R
    Oosthuyse, B
    Dewerchin, M
    Zanetti, A
    Angellilo, A
    Mattot, V
    Nuyens, D
    Lutgens, E
    Clotman, F
    de Ruiter, MC
    Gittenberger-de Groot, A
    Poelmann, R
    Lupu, F
    Herbert, JM
    Collen, D
    Dejana, E
    [J]. CELL, 1999, 98 (02) : 147 - 157
  • [9] Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
    Carmeliet, P
    Moons, L
    Luttun, A
    Vincenti, V
    Compernolle, V
    De Mol, M
    Wu, Y
    Bon, F
    Devy, L
    Beck, H
    Scholz, D
    Acker, T
    DiPalma, T
    Dewerchin, M
    Noel, A
    Stalmans, I
    Barra, A
    Blacher, S
    Vandendriessche, T
    Ponten, A
    Eriksson, U
    Plate, KH
    Foidart, JM
    Schaper, W
    Charnock-Jones, DS
    Hicklin, DJ
    Herbert, JM
    Collen, D
    Persico, MG
    [J]. NATURE MEDICINE, 2001, 7 (05) : 575 - 583
  • [10] Chadeneau C, 1996, INT J CANCER, V68, P817